ClinConnect ClinConnect Logo
Search / Trial NCT03549754

iCaReMe Global Registry

Launched by ASTRAZENECA · May 29, 2018

Trial Information

Current as of July 24, 2025

Recruiting

Keywords

Registry Type 2 Diabetes T2 Dm Chronic Kidney Disease Ckd Hypertension Htn Adult Population Heart Failure Hf Early Cardiorenal Complications

ClinConnect Summary

The iCaReMe Global Registry is a clinical trial aimed at gathering important information about patients with type 2 diabetes, hypertension (high blood pressure), chronic kidney disease, and heart failure. The goal is to understand how these conditions are managed in everyday life, how often patients visit healthcare providers, and what health outcomes they experience. This study will help improve care for people living with these conditions.

To participate in this registry, you need to be at least 18 years old and have one or more of the conditions mentioned above. You will need to provide your consent, which means you agree to join the study and understand what it involves. It's important to know that if you have a serious health issue that might limit your life expectancy to less than a year, or if you are already part of another trial, you won't be eligible to join this one. Participants can expect to share their health information, which will contribute to a better understanding of how to manage these diseases effectively.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Being 18 years or older
  • 2. Having type 2 diabetes, Hypertension, Heart Failure and/or chronic kidney disease
  • 3. Providing written informed consent to participate in the registry
  • Exclusion Criteria:
  • 1. Having a life-threatening co-morbidity with life expectancy below 1 year
  • 2. Participating in an interventional trial requiring informed consent

About Astrazeneca

AstraZeneca is a global biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative medicines across various therapeutic areas, including oncology, cardiovascular, respiratory, and autoimmune diseases. With a strong commitment to scientific research and patient-centric solutions, AstraZeneca leverages cutting-edge technology and a robust pipeline to address unmet medical needs. The company collaborates with healthcare professionals, academic institutions, and other organizations to advance clinical trials and deliver transformative therapies, aiming to improve health outcomes and enhance the quality of life for patients worldwide.

Locations

Taichung, , Taiwan

Taipei, , Taiwan

Kuala Lumpur, , Malaysia

Ahmedabad, , India

Guadalajara, Jalisco, Mexico

Larissa, , Greece

Chihuahua, , Mexico

São Paulo, , Brazil

Lima, , Peru

Campina Grande Do Sul, Paraná, Brazil

Parow, , South Africa

Sharjah, , United Arab Emirates

San Juan Del Rio, Queretaro, Mexico

Pune, Maharashtra, India

Tainan City, , Taiwan

San Jose, Los Yoses, San Pedro, Costa Rica

Fleming, Alexandria, Egypt

Downtown, Assiut, Egypt

Haram, Cairo, Egypt

Ahmedabad, Gujarat, India

Rohtak, Haryana, India

Bangalore, Karnataka, India

Chennai, Royapuram, India

Kolkata, West Bengal, India

Delhi, , India

Pondicherry, , India

Vadodara, , India

Johor Darul Takzim, Iskandar Puteri, Malaysia

Monterrey, Nuevo Leon, Mexico

Campina Grande Do Sul, , Brazil

Santa Cruz Do Sul, , Brazil

Los Yoses, San José, Costa Rica

Guayaquil, Guayas, Ecuador

Manta, Manabi, Ecuador

Quito, , Ecuador

Al Kasr Al Eini, Cairo, Egypt

El Matareya, Cairo, Egypt

El Nozha, Cairo, Egypt

Maadi, Cairo, Egypt

Ramses, Cairo, Egypt

Roxy, Cairo, Egypt

Agouza, Giza, Egypt

Faisal, Giza, Egypt

Kumasi, Ashanti Region, Ghana

Attica, Athens, Greece

Attiki, Athens, Greece

Chalkidiki, Nea Moudania, Greece

Lamia, , Greece

Thessaloniki, , Greece

Gujarat, Ahmedabad, India

Jambi, Telanaipura, Indonesia

Eldoret, , Kenya

Jalisco, Guadalajara, Mexico

Nuevo Leon, Guadalupe, Mexico

Queretaro, San Juan Del Río, Mexico

Lagos, , Nigeria

Dasmarinas, Cavite, Philippines

Marikina, Metro Manila, Philippines

Pasig, Metro Manila, Philippines

Antipolo, Rizal, Philippines

Cebu, , Philippines

Iloilo, , Philippines

Benoni, Johannesburg, South Africa

Durban, Kwazulu Natal, South Africa

Taoyuan City, , Taiwan

São Caetano Do Sul, , Brazil

Salvador, Bahia, Brazil

Fortaleza, Ceará, Brazil

Brasília, Distrito Federal, Brazil

Colatina, Espírito Santo (Es), Brazil

Poços De Caldas, Minas Gerais, Brazil

Teresina, Piauí (Pi), Brazil

Santa Cruz Do Sul, Rio Grande Do Sul (Rs), Brazil

Goiânia, State Of Goiás, Brazil

Joinville, State Of Santa Catarina, Brazil

Bragança Paulist, São Paulo, Brazil

São Caetano Do Sul, São Paulo, Brazil

Providencia, Santiago Metropolitan Region, Chile

Abidjan, , Côte D'ivoire

Wan Chai District, , Hong Kong

Sulaimani, , Iraq

Almaty, , Kazakhstan

Nairobi, , Kenya

Kuala Lumpur, Selangor, , Malaysia

León, Guanajuato, Mexico

Ciudad De México, , Mexico

Colonia Doctores Neighborhood, , Mexico

Iztapalapa, , Mexico

Mexico, , Mexico

Gwagwalada, , Nigeria

Kano, , Nigeria

Florida, , South Africa

Umhlanga, , South Africa

Niaosong Dist, Kaohsiung, Taiwan

Changhua City, , Taiwan

Kaohsiung City, , Taiwan

Taichung City, , Taiwan

Dnipro, Dnipropetrovsk Oblast, Ukraine

Kharkiv, Kharkiv Oblast, Ukraine

Kyiv, Kyiv Oblast, Ukraine

Vinnytsia, Vinnytsia Oblast, Ukraine

Lutsk, Volyn Oblast, Ukraine

Uzhhorod, Zakarpattia Oblast, Ukraine

Zaporizhzhia, Zaporizhzhia Oblast, Ukraine

Fortaleza, , Brazil

Colatina, , Brazil

Teresina, , Brazil

Goiânia, , Brazil

Bragança Paulist, , Brazil

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials